Product Monitoring Product Monitoring
  • Home
  • Application
  • News
  • Events
  • More Information
  • Deutsch
  • English
Product Monitoring Product Monitoring
  • Home
  • Application
  • News
  • Events
  • More Information
  • Deutsch
  • English
May 19

European Medicines Agency recommends new measures to avoid application errors with Leuprorelin-containing depot medicinal products

  • 19. May 2020
  • Product Monitoring News

With the preparation and application of Leuprorelin-containing medicinal products being complicated and error-prone, the Pharmacovigilance Risk Assessment Committee (PRAC) within the European Medicines Agency recommends new measures to avoid application errors. The Committee especially advises that exclusively medical professionals who are familiar with the preparation of Leuprorelin-containing depot medicinal products should be allowed to prepare and inject them. Patients should not do this themselves. For more information please click here.

  • Facebook
  • Twitter
  • Pinterest
  • Google+
  • LinkedIn

Comments are closed.

News

  • Product Monitoring News
  • Reading Recommendations

Search

  • Privacy
  • Legal Notice

News

  • First patient survey for statutory quality assurance started
  • German Minister of the Interior wants to boost cyber security with amendment to Grundgesetz
© 2022 Consline AG - All rights reserved